- Forums
- ASX - By Stock
- APX
- Ann: Update on 1H 22 results and FY2022 outlook
Ann: Update on 1H 22 results and FY2022 outlook, page-114
-
-
- There are more pages in this discussion • 513 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add APX (ASX) to my watchlist
|
|||||
Last
50.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $110.3M |
Open | High | Low | Value | Volume |
49.5¢ | 51.0¢ | 49.5¢ | $219.4K | 438.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 114192 | 50.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.5¢ | 30687 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 114323 | 0.500 |
7 | 157498 | 0.495 |
10 | 131413 | 0.490 |
7 | 259792 | 0.485 |
8 | 77620 | 0.480 |
Price($) | Vol. | No. |
---|---|---|
0.505 | 30087 | 10 |
0.510 | 83078 | 8 |
0.515 | 64016 | 8 |
0.520 | 33393 | 4 |
0.525 | 22600 | 4 |
Last trade - 11.42am 16/07/2024 (20 minute delay) ? |
Featured News
APX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online